Millennium Pharmacon International (SDPC) — Cash Flow Reinvestment Rate

Latest as of March 2025: 0.12x

Millennium Pharmacon International (SDPC) has a Cash Flow Reinvestment Rate of 0.12x as of March 2025, reinvesting Rp8.35 Billion (capex Rp1.09 Billion plus investments Rp-7.26 Billion) from operating cash flow of Rp70.29 Billion. Explore SDPC capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.12x
(Capex + Investments) / Operating CF

Total Reinvested

Rp8.35 Billion
Capex + Investments

Operating Cash Flow

Rp70.29 Billion
IDR

Capital Expenditures

Rp1.09 Billion
IDR

Millennium Pharmacon International Cash Flow Reinvestment Rate (2004–2022)

Historical reinvestment intensity for Millennium Pharmacon International across 8 annual periods. Also explore total assets of Millennium Pharmacon International for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Millennium Pharmacon International (2004–2022)

Year-by-year capital reinvestment analysis for Millennium Pharmacon International. For live market cap and broader valuation context, see market value of Millennium Pharmacon International.

Year Reinvestment Rate Total Reinvested (IDR) Operating CF Capex YoY Change
2022 0.71x Rp29.29 Billion Rp41.00 Billion Rp14.68 Billion ▲ +571.7%
2020 0.11x Rp7.62 Billion Rp71.69 Billion Rp3.81 Billion ▼ -95.9%
2018 2.60x Rp12.30 Billion Rp4.72 Billion Rp6.35 Billion ▼ -80.8%
2017 13.60x Rp60.61 Billion Rp4.46 Billion Rp6.61 Billion ▲ +2287.6%
2012 0.57x Rp1.25 Billion Rp2.19 Billion Rp1.25 Billion ▼ -21.3%
2007 0.72x Rp3.31 Billion Rp4.57 Billion Rp3.31 Billion ▼ -26.7%
2006 0.99x Rp792.17 Million Rp802.62 Million Rp792.17 Million ▲ +59.7%
2004 0.62x Rp1.68 Billion Rp2.72 Billion Rp1.68 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow